BioNTech SE (NAS:BNTX)
$ 115.59 -1.61 (-1.37%) Market Cap: 27.71 Bil Enterprise Value: 9.82 Bil PE Ratio: 0 PB Ratio: 1.31 GF Score: 66/100

Q3 2024 BioNTech SE Earnings Call Transcript

Nov 04, 2024 / 01:00PM GMT
Release Date Price: $108.97 (-2.25%)
Operator

Welcome to BioNTech's third quarter 2024 earnings call. I would like to hand the call over to Michael Horowicz Director, Investor Relations. Please go ahead.

Michael Horowicz
Biontech SE - Associate Director, Investor Relations and Strategy

Thank you. Good morning and good afternoon. Thank you for joining BioNtech's third quarter 2024 earnings call. As a reminder, the slide that we will be using during this call and the corresponding press release we issued this morning can be found in the Investor Relations section of our website.

On the next slide, you will see our forward-looking comments disclaimer. Additional information about these statements and other risks are described in our filings with the US Securities and Exchange Commission. Forward-looking statements in this call are subject to significant risks and uncertainties and speak only as of the date of this conference call. We undertake no obligation to update or revise any of these statements.

On Slide 3, you can find the agenda for today's call. Today, I am joined by the following

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot